Preliminary results of an open label randomised clinical trial comparing mycophenylate mofetil (MMF) vs intravenous cyclophosphamide as induction therapy for severe lupus nephritis

Authors
Category Primary study
JournalArthritis Rheum
Year 2004
This article has no abstract
Epistemonikos ID: d0a1d691e6a18045660eb9167a41d92852807d01
First added on: Apr 23, 2017